Ideaya Biosciences Inc (IDYA) Financials

$37.73

$0.07 (0.19%)

As on 16-Sep-2026 16:00EDT

Market cap

$3,627 Mln

Revenue (TTM)

$234 Mln

P/E Ratio

--

P/B Ratio

3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	234.13	218.71	7.00	23.39	50.93	27.94
Cost of Revenue	265.32	314.70	3.83	4.01	2.10	1.73
Gross Profit	-31.19	-95.99	3.17	19.38	50.93	27.94
Operating Expenses	185.76	63.32	330.14	153.81	113.43	78.21
Operating Profit (EBIT)	-216.95	-159.31	-326.98	-134.43	-62.50	-50.27
Other Income	--	--	--	--	3.85	0.51
Profit before Tax	-175.02	-113.70	-274.48	-112.96	-58.66	-49.76
Provision for Tax	--	--	--	3.84	-3.85	-2.23
Profit after Tax (Net Income)	-175.02	-113.70	-274.48	-112.96	-54.81	-47.53
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-58.66	-49.76

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	1,198.91	1,022.93	1,059.15	621.09	349.46	301.51
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	28.12	27.58	18.87	1.13	6.80	34.67
Current Liabilities	82.68	58.82	46.07	27.10	31.72	45.16
Total Liabilities	1,392.38	1,109.32	1,124.09	649.32	387.97	381.35

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	445.67	442.60	434.38	116.68	17.52	130.35
Current Assets	864.03	666.73	689.71	532.63	370.45	251.00
Total Assets	1,392.38	1,109.32	1,124.09	649.32	387.97	381.35
Total Debt*	29.31	27.91	19.17	2.87	3.48	5.18
Net Current Assets	781.35	607.91	643.64	505.53	338.74	205.84

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-71.10	-247.58	-115.22	-87.18	-55.78
Cash Flow from Investing Activities	--	69.98	-502.56	-158.46	-33.40	-69.67
Cash from Financing Activities	--	29.78	677.55	362.72	97.17	145.45
Net Cash Inflow / Outflow	--	--	--	--	-23.41	20.01

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.94	-1.28	-3.14	-1.73	-1.14	-1.23
Cash EPS ($)	--	-1.23	-3.10	-1.67	-1.10	-1.19
Adjusted Book Value ($)	--	11.55	12.13	9.52	7.26	7.83
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.80	-2.83	-1.77	-1.81	-1.45
Free Cash Flow per Share ($)	--	-0.83	-2.88	-1.80	-1.88	-1.52

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-10.68	-32.25	-23.13	-16.62	-18.58
ROE (%)	-15.75	-10.92	-32.67	-23.28	-16.84	-19.02
ROA (%)	-14.06	-10.18	-30.95	-21.78	-14.25	-13.99
EBIT Margin (%)	-92.66	-72.84	-3,921.10	-483.05	-122.72	-179.91
Net Margin (%)	-74.75	-51.99	-3,921.10	-483.05	-100.05	-167.09
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	3,244.67	30.24	-0.70	-0.54	0.82	0.43
EBIT Growth (%)	38.94	41.96	-142.98	-80.73	-24.34	-42.22
Net Profit Growth (%)	47.25	58.58	-142.98	-106.10	-15.31	-47.31
EPS Growth (%)	48.68	0.59	-0.82	-0.52	0.08	-0.12
Book Value Growth (%)	20.06	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-26.93	-8.18	-20.55	-15.96	-19.15
Price / Book Value	3.01	2.99	2.12	3.74	2.50	3.02
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-7.80	-15.84	-5.87	-16.51	-8.50	-13.77
Close Price ($)	37.27	34.57	25.70	35.58	18.17	23.64
High Price ($)	39.28	37.08	47.74	36.51	24.09	28.00
Low Price ($)	20.50	13.45	24.20	13.29	8.14	13.16
Market Cap ($ Cr)	3,627.04	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.03	0.02	0.00	0.01	0.02
Short term debt to equity ratio	0.00	0.00	0.00	0.00	0.01	0.01
Current Ratio	10.45	11.34	14.97	19.65	11.68	5.56
Quick Ratio	10.45	--	--	0.00	11.94	8.24
Interest Coverage	--	--	--	-5.26	-16.25	-99.34

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	6.58	2.73	0.04	0.08	0.41	3.95
Asset Turnover	0.19	0.20	0.01	0.05	0.13	0.08
Receivable days	--	4.99	0.55	1.79	4.71	19.48
Inventory Days	--	--	50,740.03	23,889.66	-11,266.08	-25,682.47
Payable days	--	19.15	1,048.83	495.66	554.57	323.22
Cash Conversion Cycle	--	--	49,691.74	23,395.79	-11,815.93	-25,986.22

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.